NRGN and Alzheimer disease: Remarkably, when compared to stable MCI cases and normal control participants, changes in plasma NED levels of p-ptau, Aβ42, neurogranin, and repressor element 1-silencing transcription factor were observed among AD and MCI cases that transitioned to AD within 36 months [95].